Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis

Objective. To investigate whether the achievement of inactive disease in the first 5 years predicts a more favorable outcome of children with juvenile idiopathic arthritis (JIA). Methods. We reviewed clinical charts of 123 patients who started taking methotrexate, were followed for at least 5 years, and received a yearly assessment in the first 5 years. At each yearly visit, the presence of inactive disease was assessed. Patients were divided into 3 groups: (1) patients who never reached inactive disease; (2) patients who reached inactive disease in only 1 visit; and (3) patients who reached inactive disease in ≥ 2 visits. Outcome was evaluated after 6 to 18 years (median 7.1 yrs) by assessing the following clinical measures: restricted joint count, Childhood Health Assessment Questionnaire (CHAQ), Juvenile Arthritis Damage Index (JADI), and Poznanski score of radiographic damage. Results. In the first 5 years, 62 patients (50.4%) were noted to have active disease at their yearly visit, 40 patients (32.5%) were noted to have inactive disease only once, and 21 patients (17.1%) were noted to have inactive disease in ≥ 2 visits. Patients who achieved inactive disease 1 or more times had lower restricted joint count (p = 0.007) and JADI-Articular score (p = 0.004) at last followup visit than those who never reached such a state. A similar trend, although not significant, was observed for CHAQ and Poznanski score of radiographic damage. Conclusion. Attainment of the state of inactive disease at least once in the first 5 years was found to be associated with less longterm joint damage and with a trend toward less functional impairment.

[1]  M. Beresford,et al.  Juvenile Idiopathic Arthritis , 2011, Paediatric drugs.

[2]  A. Martini,et al.  Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.

[3]  A. Martini,et al.  The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis , 2007, Annals of the rheumatic diseases.

[4]  A. Martini,et al.  Development and validation of a preliminary definition of minimal disease activity in juvenile idiopathic arthritis , 2008 .

[5]  A. Martini,et al.  Remission in juvenile idiopathic arthritis. , 2006, Clinical and experimental rheumatology.

[6]  R. Schneider,et al.  Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. , 2006, Arthritis and rheumatism.

[7]  Bin Huang,et al.  Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. , 2006, The Journal of rheumatology.

[8]  Bin Huang,et al.  Patterns of clinical remission in select categories of juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[9]  A. Silman,et al.  Outcome following onset of juvenile idiopathic inflammatory arthritis: I. frequency of different outcomes. , 2005, Rheumatology.

[10]  A. Martini,et al.  Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[11]  A. Martini,et al.  Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis , 1995, Clinical Rheumatology.

[12]  E. Giannini,et al.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[13]  A. McMahon,et al.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial , 2004, The Lancet.

[14]  A Ravelli,et al.  Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.

[15]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[16]  A. Martini,et al.  Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.

[17]  A. Martini,et al.  Early predictors of outcome in juvenile idiopathic arthritis. , 2003, Clinical and experimental rheumatology.

[18]  K. Oen Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. , 2002, Best practice & research. Clinical rheumatology.

[19]  L. Kiemeney,et al.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[20]  S. Cavuto,et al.  The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). , 2001, Clinical and experimental rheumatology.

[21]  A. Martini,et al.  Correlation between conventional disease activity measures in juvenile chronic arthritis , 1997, Annals of the rheumatic diseases.

[22]  M. V. van Leeuwen,et al.  Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. , 1997, The Journal of rheumatology.

[23]  J. Fries,et al.  Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. , 1996, Arthritis and rheumatism.

[24]  D. Lovell,et al.  Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents. , 1991, Arthritis and rheumatism.

[25]  D. Lovell,et al.  Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Scale. , 1989, Arthritis and rheumatism.

[26]  P. Dawes,et al.  Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. , 1986, British journal of rheumatology.

[27]  A. Poznanski,et al.  Carpal length in children--a useful measurement in the diagnosis of rheumatoid arthritis and some concenital malformation syndromes. , 1978, Radiology.